{"id":772610,"date":"2023-07-26T11:01:44","date_gmt":"2023-07-26T15:01:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/"},"modified":"2023-07-26T11:01:44","modified_gmt":"2023-07-26T15:01:44","slug":"oculis-announces-to-present-at-upcoming-august-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/","title":{"rendered":"Oculis Announces to Present at Upcoming August Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ZUG, Switzerland, and BOSTON, July  26, 2023  (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that it will participate at the following upcoming investor conferences:<\/p>\n<p align=\"justify\">\n        <strong>BTIG Virtual Biotechnology Conference 2023<\/strong><br \/>\n        <br \/>Format: One-on-one meetings<br \/>Date: August 7 \u2013 8, 2023<br \/>Location: Virtual<\/p>\n<p align=\"justify\">\n        <strong>Wedbush PacGrow Healthcare Conference<\/strong><br \/>\n        <br \/>Format: One-on-one meetings<br \/>Date and time: August 8 \u2013 9, 2023<br \/>Location: New York, New York<\/p>\n<p align=\"justify\">\n        <strong>H.C. Wainwright 3<\/strong><br \/>\n        <sup><br \/>\n          <strong>rd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Ophthalmology Virtual Conference<\/strong><br \/>\n        <br \/>Format: Company presentation <br \/>Date and time: Available on-demand Wednesday, August 16, 2023 at 7:00am ET<br \/>Location: Virtual<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Bj5Mauz9RhBNfDdwgSM1R4ItsDGHpZt9fXyktB5WedzTjGzCeoget1B-SMk2QwtYMUNmapx6oRKDxI3g2SU-sSXpFL2Ms0JTv1D0kk7Bns8ceFTQEgg3XGdzDaiGDMQnEQvQd6mWXiW5sixs3-1Goq7e2oaTnqxdGX3BB-heXYolQktBL5K8yxJ1PvOdEv6goa5F0SAEwXkV74HgAb3Tg==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events\/view\/1f5fe5a8-e1b8-43f9-9fb5-0775acd23032<\/a><\/p>\n<p align=\"justify\">The Oculis management team will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at the sponsoring institutions to request meetings. Links to access company presentation for select events, when available, will be posted to Oculis\u2019s website on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nJtn8IcaqggYBlb-fDhdgzjeTt3SK0HdnjBOT4PVbt08SkHeHN812-6d7FM3yqIyiFDxUBGbnM-JdX9MRbWOu-eOoU0nTF1OJuiio7Xo5aXr5OKFDcWwroynCKouCQlfvXp0LV0sTulDJoE7pFbr1g==\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a> page of the Investors section.<\/p>\n<p>\n        <strong>About Oculis<\/strong>\n      <\/p>\n<p align=\"justify\">Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis\u2019s highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Oculis\u2019s goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.<\/p>\n<p align=\"justify\">For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZLpjplxkYzUCCcZFdB-77BFN4shxr-1485ZoX2U8J1lla1jqLMSHDtBzTAIXj5NpfKHbiaBmUenZUM105EWqMw==\" rel=\"nofollow noopener\" target=\"_blank\">www.oculis.com<\/a><\/p>\n<p>\n        <strong>Oculis Contacts<\/strong>\n      <\/p>\n<p>Mrs. Sylvia Cheung, CFO<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x4MtgMfxWxAL2Pv1cdP4RrPM2wOcZ4H9r2xOPhTEF3cf0my3pthJJKv53TcxtNW2_J-PEppMEhexe4-Bi1T37l9DhEpw5YgnQPCeqtEpUQHjDgdwV9JDsXuU4QuPHgfkJ7i4NsTZ3lImiwygCluSrSVHgSMkhORtakDDG-8KFSGqarbRXeCaLTq-VDUKw_URdYkAUgYHoGIMPKmri_1XTZUZapF1gnK-f9qFd0xbfH2SoUDGcF9Xg_7jlzCHDvNQpQ7_aCI06N72lZcJJEO96IW5B8G60I_08dEtZllkWCM=\" rel=\"nofollow noopener\" target=\"_blank\"><u>sylvia.cheung@oculis.com<\/u><\/a><\/p>\n<p>\n        <strong>Investor &amp; Media Relations <\/strong>\n      <\/p>\n<p>LifeSci Advisors<br \/>Corey Davis, Ph.D.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3dtG7eudIKbH_MfertEqeTDZ_XHNAbsanPTMqcgEq2B0pzGvxPOhNOLRLVldmTMkMeMmiY5N1e6WqlYzXl_eICYjh6Gc-yXFSMFbX2yB0XXjneGQe_Aq-PBzWXGn_uT6\" rel=\"nofollow noopener\" target=\"_blank\"><u>cdavis@lifesciadvisors.com<\/u><\/a><br \/>1-212-915-2577<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NTVhM2ViZTUtN2Q5MS00MWNkLWI4OTItMGZjNTJjMGNhODBiLTEyMDA1NzY=\/tiny\/Oculis-SA.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ZUG, Switzerland, and BOSTON, July 26, 2023 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that it will participate at the following upcoming investor conferences: BTIG Virtual Biotechnology Conference 2023 Format: One-on-one meetingsDate: August 7 \u2013 8, 2023Location: Virtual Wedbush PacGrow Healthcare Conference Format: One-on-one meetingsDate and time: August 8 \u2013 9, 2023Location: New York, New York H.C. Wainwright 3 rd Annual Ophthalmology Virtual Conference Format: Company presentation Date and time: Available on-demand Wednesday, August 16, 2023 at 7:00am ETLocation: VirtualWebcast Link: https:\/\/journey.ct.events\/view\/1f5fe5a8-e1b8-43f9-9fb5-0775acd23032 The Oculis management team will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oculis Announces to Present at Upcoming August Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-772610","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oculis Announces to Present at Upcoming August Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oculis Announces to Present at Upcoming August Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ZUG, Switzerland, and BOSTON, July 26, 2023 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that it will participate at the following upcoming investor conferences: BTIG Virtual Biotechnology Conference 2023 Format: One-on-one meetingsDate: August 7 \u2013 8, 2023Location: Virtual Wedbush PacGrow Healthcare Conference Format: One-on-one meetingsDate and time: August 8 \u2013 9, 2023Location: New York, New York H.C. Wainwright 3 rd Annual Ophthalmology Virtual Conference Format: Company presentation Date and time: Available on-demand Wednesday, August 16, 2023 at 7:00am ETLocation: VirtualWebcast Link: https:\/\/journey.ct.events\/view\/1f5fe5a8-e1b8-43f9-9fb5-0775acd23032 The Oculis management team will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at &hellip; Continue reading &quot;Oculis Announces to Present at Upcoming August Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-26T15:01:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oculis Announces to Present at Upcoming August Investor Conferences\",\"datePublished\":\"2023-07-26T15:01:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/\"},\"wordCount\":360,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/\",\"name\":\"Oculis Announces to Present at Upcoming August Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==\",\"datePublished\":\"2023-07-26T15:01:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-announces-to-present-at-upcoming-august-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oculis Announces to Present at Upcoming August Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oculis Announces to Present at Upcoming August Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Oculis Announces to Present at Upcoming August Investor Conferences - Market Newsdesk","og_description":"ZUG, Switzerland, and BOSTON, July 26, 2023 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that it will participate at the following upcoming investor conferences: BTIG Virtual Biotechnology Conference 2023 Format: One-on-one meetingsDate: August 7 \u2013 8, 2023Location: Virtual Wedbush PacGrow Healthcare Conference Format: One-on-one meetingsDate and time: August 8 \u2013 9, 2023Location: New York, New York H.C. Wainwright 3 rd Annual Ophthalmology Virtual Conference Format: Company presentation Date and time: Available on-demand Wednesday, August 16, 2023 at 7:00am ETLocation: VirtualWebcast Link: https:\/\/journey.ct.events\/view\/1f5fe5a8-e1b8-43f9-9fb5-0775acd23032 The Oculis management team will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at &hellip; Continue reading \"Oculis Announces to Present at Upcoming August Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-26T15:01:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oculis Announces to Present at Upcoming August Investor Conferences","datePublished":"2023-07-26T15:01:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/"},"wordCount":360,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/","name":"Oculis Announces to Present at Upcoming August Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==","datePublished":"2023-07-26T15:01:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgzMTU1NCM0MDE1ODYzMTcjMjE4OTAyMw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-announces-to-present-at-upcoming-august-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oculis Announces to Present at Upcoming August Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=772610"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772610\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=772610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=772610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=772610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}